Thermo Fisher Scientific Balance Sheet
TMO / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Thermo Fisher Scientific had $110.3B in total assets and $53.4B in shareholders' equity as of FY2025. Total debt was $39.2B against $9.9B in cash, resulting in $29.3B net debt.
Based on SEC 10-K filings.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.9B | $4.0B | $8.1B | $8.5B | $4.5B | $10.3B | $2.4B | $2.1B | $1.3B | $786.0M | $452.1M | $1.3B | $5.8B | $805.6M | $1.0B |
| Accounts Receivable | $8.9B | $8.2B | $8.2B | $8.1B | $8.0B | $5.7B | $4.3B | $3.9B | $3.9B | $3.0B | $2.5B | $2.5B | $1.9B | $1.8B | $1.8B |
| Inventory | $5.4B | $5.0B | $5.1B | $5.6B | $5.1B | $4.0B | $3.4B | $2.7B | $3.0B | $2.2B | $2.0B | $1.9B | $1.5B | $1.4B | $1.3B |
| Current Assets | $28.7B | $22.1B | $24.6B | $25.2B | $20.1B | $22.0B | $11.9B | $10.6B | $9.4B | $7.0B | $5.7B | $6.5B | $9.9B | $4.8B | $4.8B |
| PP&E (Net) | $10.6B | $9.3B | $9.4B | $9.3B | $8.3B | $5.9B | $4.7B | $4.2B | $4.0B | $2.6B | $2.4B | $2.4B | $1.8B | $1.7B | $1.6B |
| Goodwill | $49.4B | $45.9B | $41.2B | $41.9B | $26.0B | $26.0B | $25.7B | $25.3B | $25.3B | $21.3B | $18.8B | $18.8B | $12.5B | $12.5B | $12.0B |
| Total Assets | $110.3B | $97.3B | $97.2B | $95.1B | $69.1B | $69.1B | $58.4B | $56.2B | $56.7B | $45.9B | $40.8B | $42.9B | $31.9B | $27.4B | $26.8B |
| Current Liabilities | $15.2B | $13.3B | $14.0B | $17.0B | $13.4B | $10.3B | $6.2B | $6.1B | $7.0B | $4.9B | $4.1B | $5.3B | $3.1B | $2.1B | $3.1B |
| Total Debt | $39.2B | $31.1B | $34.7B | $34.3B | $34.7B | $21.7B | $17.8B | $19.0B | - | - | - | - | - | - | - |
| Shareholders' Equity | $53.4B | $49.6B | $46.7B | $44.0B | $40.8B | $34.5B | $29.7B | $27.6B | $25.4B | $21.5B | $21.4B | $20.5B | $16.9B | $15.5B | $15.0B |